Načítá se...
Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity
The apoptosis-inducing peptide kla (KLAKLAK)(2) possesses the ability to disrupt mitochondrial membranes and induce cancer cell apoptosis, but this peptide has a poor eukaryotic cell-penetrating potential. Thus, it requires the assistance of other peptides for effective translocation at micromolar c...
Uloženo v:
| Vydáno v: | PLoS One |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6839859/ https://ncbi.nlm.nih.gov/pubmed/31703065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0223738 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|